On December 11, 2024, the U.S. Department of Justice (DOJ) and the Federal Trade Commission (FTC) (together, “the Agencies”) jointly withdrew the 2000 Antitrust Guidelines for Collaborations Among Competitors (“Guidelines”)....more
1/6/2025
/ Antitrust Provisions ,
Collaboration ,
Competition ,
Department of Justice (DOJ) ,
Distribution Rules ,
Enforcement ,
Federal Trade Commission (FTC) ,
Information Sharing ,
Joint Venture ,
Safe Harbors ,
Sales
The Federal Trade Commission (FTC) recently submitted a comment to the U.S. Copyright Office in response to its “Notice of Inquiry” in the Federal Register examining copyright issues related to artificial intelligence (AI)....more
11/28/2023
/ Artificial Intelligence ,
Civil Investigation Demand ,
Competition ,
Compliance ,
Copyright Office ,
Data Collection ,
Deep Fake ,
Federal Trade Commission (FTC) ,
FTC Act ,
Intellectual Property Protection ,
Notice of Inquiry ,
Software Licenses ,
Training
Health care companies are increasingly using artificial intelligence (AI) to create innovations, set prices, and compete with rivals. At the same time, federal and state antitrust enforcers are finding new ways to apply...more
4/26/2023
/ Antitrust Provisions ,
Artificial Intelligence ,
Collusion ,
Competition ,
Compliance ,
Enforcement ,
Federal Trade Commission (FTC) ,
Healthcare ,
Horizontal Mergers ,
Medical Devices ,
Mergers ,
Technology Sector
On February 3, 2023, the U.S. Department of Justice’s Antitrust Division (DOJ) announced that it is withdrawing three policy statements the DOJ and Federal Trade Commission (FTC) issued between 1993 and 2011, related to...more
2/7/2023
/ Antitrust Provisions ,
Competition ,
Department of Justice (DOJ) ,
Executive Orders ,
Federal Trade Commission (FTC) ,
Healthcare ,
Information Sharing ,
Joe Biden ,
Safe Harbors ,
Sherman Act ,
Third-Party Service Provider
Earlier this month — July 9, 2022 — marked the one-year anniversary of President Biden’s Executive Order on Promoting Competition in the American Economy (Executive Order). The Executive Order was notable in its breadth and...more
7/27/2022
/ Beverage Manufacturers ,
Biden Administration ,
Competition ,
Department of Justice (DOJ) ,
Enforcement ,
Executive Orders ,
Federal Trade Commission (FTC) ,
Food Manufacturers ,
FRAND ,
FTC Act ,
Healthcare ,
Manufacturers ,
Memorandum of Understanding ,
Mergers ,
NIST ,
NLRB ,
Pharmaceutical Industry ,
ROI ,
USDA ,
USPTO
In remarks on September 29, 2021, a senior official from the Department of Justice Antitrust Division (DOJ) outlined the agency’s shift in approach to issues surrounding technology industry standards. The remarks foreshadowed...more
On Friday, July 9, 2021, President Biden issued a sweeping Executive Order that could have far-reaching implications for businesses across a broad spectrum of industries. The Executive Order takes a government-wide approach...more
7/15/2021
/ Anti-Competitive ,
Antitrust Violations ,
Competition ,
Department of Justice (DOJ) ,
Enforcement Actions ,
Executive Orders ,
Federal Trade Commission (FTC) ,
FTC Act ,
Healthcare ,
Joe Biden ,
Manufacturers ,
Mergers ,
No-Poaching ,
Non-Compete Agreements ,
Pharmaceutical Industry ,
Wage-Fixing
On November 7, 2017, the Federal Trade Commission (FTC) released an advisory opinion confirming that a non-profit hospital in New York may sell discounted prescription drugs to the employees of an affiliated medical practice...more
11/16/2017
/ 501(c)(3) ,
Advisory Opinions ,
Commodities ,
Competition ,
Federal Trade Commission (FTC) ,
Healthcare Facilities ,
Hospitals ,
Non-Profit Hospitals ,
Nonprofits ,
Pharmaceutical Industry ,
Price Discrimination ,
Robinson-Patman Act